J. Hatzimanolis et al., NEUROCHEMICAL VARIABLES IN SCHIZOPHRENIC-PATIENTS DURING SWITCHING FROM NEUROLEPTICS TO CLOZAPINE, Progress in neuro-psychopharmacology & biological psychiatry, 22(7), 1998, pp. 1077-1085
1. The study aimed to search for the effect of clozapine on the levels
of the main metabolites of dopamine homovanillic acid (HVA), serotoni
n 5-hydroxyindoleacetic acid (5-HIAA) and norepinephrine 3-methoxy-4-h
ydroxyphenylglycol (MHPG) in urine als well as on plasma levels of HVA
, 5-HIAA, prolactin (PRL) and cortisol. 2. Seventeen male patients dia
gnosed as suffering from DSM-IIIR schizophrenia completed the study. 3
. The patients were switched from classical antipsychotics to clozapin
e. After six weeks treatment with clozapine the severity of psychopath
ology (total BPRS score) decreased significantly (p=0.00004). pHVA and
-5-HIAA did not change significantly. uMHPG increased significantly (
p=0.017). Both PRL and cortisol levels decreased significantly (p=0.00
02, p=0.032 respectively). Patients with high HVA levels in both plasm
a and urine at baseline had a lower BPRS score at the end of treatment
period (p=0.0001, p=0.049 respectively).